Previous treatment as a confounding variable in studies with novel antipsychotics: Two cases of high dopamine-2 receptor occupancy with quetiapine

Psychopharmacology

Volumn 133, Issue 1, 1997, Pages 102-105

  Tauscher, Johannes ^a   Küfferle, Bernd ^a   Asenbaum, Susanne ^a   Brücke, Thomas ^a   Kasper, Siegfried ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Clopenthixol decanoate; Dopamine 2 receptors; Haloperidol; IBZM SPECT; Quetiapine

Indexed keywords

CLOPENTHIXOL DECANOATE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; QUETIAPINE;

ARTICLE; CASE REPORT; DRUG RECEPTOR BINDING; HUMAN; IMAGING; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANTIPSYCHOTIC AGENTS; BENZAMIDES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORPUS STRIATUM; DIBENZOTHIAZEPINES; HUMANS; IODINE RADIOISOTOPES; MALE; PYRROLIDINES; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030882188     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050378     Document Type: Article

References (12)

1. Baron JC, Martinot JL, Cambon H, Boulenger JP, Poirier MF, Caillard V, Blin J, Hurfed JD, Loc'h C, Maziere B (1989) Striatal dopamine receptor occupancy following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 99:463-472
2. Borison RL, Arvanitis LA, Miller BG (1996) ICI 204,636, an atypical antipsychotic: ellicacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol 16:158-169
3. 2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab 11[2]:220-228
4. Gefvert O, Lindstrom LH, Langstrom B, Bergstrom M, Lundberg T, Yates RA (1996) Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 mg Seroquel™ TID. Eur Neuropsychopharmacol 6[Suppl 3]:74
5. 2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45: 71-76
6. 11C] raclopride. Arch Gen Psychiatry 47:213-219
7. 2 receptor blockade after depot neuroleptics. J Neural Transm [Gen Sect] 94:217-221
8. 2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Am J Psychiatry 153[2]:183-190
9. Küfferle B, Brücke T, Topitz-Schratzberger A, Tauscher J, Gössler R, Vesely C, Asenbaum S, Podreka I, Kasper S (1996) Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone. Psychiatr Res Neuroimaging 68: 23-30
10. Küfferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brücke T, Kasper S (1997) IBZM SPECT imaging of dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol. Psychopharmacology (in press)
11. Schotte A, Janssen PFM, Gommeren W, Luyten WHML, Van Gompel P, Lesage AS, De Loore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57-73
12. 2 dopamine receptors in drug-naive schizophrenics. Science 234:1558-1563